PSG Phosphagen.

    RNS Number : 2336F
  Phosphagenics Limited
  07 October 2008
   
                                                               Phosphagenics Limited
    Presentation at the Annual Pain Therapeutics Summit 2008


    Phosphagenics Limited ("Phosphagenics") (AIM: PSG) advises that Mr Fred Banti, Senior VP and Corporate Development, will today make a
presentation on "Delivering Pain Drugs Topically and Systemically" to the 2nd Annual Pain Therapeutics Summit 2008 in New Jersey, USA. 

    Presently, the market for pharmaceuticals designed to treat pain is worth over $30 billion. The dynamics of the global pain market have
been altered greatly over the past few years. This summit is being organised to provide an integral forum for a critical examination of the
trends and issues facing the field of pain therapeutics. Key industry leaders were invited to present cutting-edge drug discovery science
and preclinical development trends. 

    A copy of the presentation which will be given by Mr Fred Banti at this summit may be viewed on the Phosphagenics' website at:

    http://www.phosphagenics.com.au/documents/07_10_08_Phosphagenics_presenta tion_at_the_annual_pain_therapeutics_summit_2008.pdf


 Mary McSwiggan   Phosphagenics Limited                    Tel +61 3 9605 5907
 (Investor
 Relations
 Manager)

 Mourice Garbutt  Phosphagenics Limited                   Tel +61 3 9605 5917
 (Company
 Secretary)

 Hugh Field       Collins Stewart Europe Limited (Nomad)  Tel +44 20 7523 8325


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
MSCFGMGGVNDGRZG

Phosphagen. (LSE:PSG)
Historical Stock Chart
From May 2024 to Jun 2024

Phosphagen. (LSE:PSG)
Historical Stock Chart
From Jun 2023 to Jun 2024